Clinical Trials Directory

Trials / Unknown

UnknownNCT00006068

Does Islet Transplantation Eliminate Hypoglycemia?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
National Center for Research Resources (NCRR) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Low blood sugar (hypoglycemia) is a recurrent problem for many people with diabetes. Successful transplantation of clusters (islets) of normal cells, that include those which produce the sugar-lowering hormone insulin, from the pancreas of a person who did not have diabetes into a person with diabetes should eliminate high blood sugar levels. We wish to determine if it will also eliminate low blood sugar. To do so we will give insulin to lower the blood sugar, measure the levels of the hormones that normally raise blood sugar levels (e.g., glucagon and epinephrine) and then stop the insulin and see if blood sugar levels return to normal. Because we anticipate that the transplanted islets will produce insulin, but not glucagon, this study may also tell us if regulated insulin production alone can prevent hypoglycemia in humans.

Conditions

Interventions

TypeNameDescription
PROCEDUREPancreatic Islet Transplantation

Timeline

First posted
2000-07-19
Last updated
2005-06-24

Source: ClinicalTrials.gov record NCT00006068. Inclusion in this directory is not an endorsement.

Does Islet Transplantation Eliminate Hypoglycemia? (NCT00006068) · Clinical Trials Directory